EUVIMEDObjevte EUVIMED
FallberichtOpen access

Atypical Fibroxanthoma Presenting as a Rapidly Enlarging Tender Papule: Case Report

Elizabeth Tchernogorova, Nicole Skalka, Mary Tidwell, Binh Minh Nguyen, Julien Lanoue, Robin Burger, McKenna Abercrombie

JMIR Dermatology · 2026-10-30 · 9 · e84550-e84550

DOI: 10.2196/84550 ↗

At a glance

Fallbericht in JMIR Dermatology, published online on 2026-10-30. Written by Elizabeth Tchernogorova and 6 co-authors. Institution: Rocky Vista University, Ivins, UT, United States. Major MEDLINE topics: Xanthomatosis, Skin Neoplasms, Skin. 10 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Atypical fibroxanthoma (AFX) is a rare dermal mesenchymal neoplasm that is most commonly identified on sun-exposed areas of the head and neck of older adults. Presentation on the dorsal hand is uncommon.

Objective

This report presents a rare case of AFX, its clinical presentation, histopathology, and treatment, and discusses the use of immunohistochemistry as a method in diagnosing AFX.

Methods

We evaluated a 67-year-old woman with a history of basal cell and squamous cell carcinomas who presented with a rapidly enlarging, tender papule on the dorsal aspect of her left hand. Prior topical 5-fluorouracil therapy was ineffective. Histopathologic examination demonstrated findings favoring AFX, and treatment was initiated. A literature review was performed to contextualize this case among previously reported instances of AFX.

Results

Clinical examination revealed a 1.2-cm, dome-shaped, erythematous papule. Histopathology demonstrated a dermal-based pleomorphic spindle cell neoplasm with brisk mitotic activity. Immunohistochemistry showed positivity for CD68 and CD10, with negative staining for SOX10, PRAME, pankeratin, p40, SMA, desmin, and CD34. The morphologic and immunohistochemical findings favored AFX. The tumor was completely excised via Mohs micrographic surgery (MMS) in a single stage with negative margins. No adjuvant therapy was required.

Conclusions

AFX remains a diagnosis of exclusion requiring comprehensive immunohistochemistry to distinguish it from morphologic mimics with aggressive biologic behavior. This case highlights that MMS is the preferred treatment for AFX, offering the lowest recurrence rates with maximal tissue conservation.

Subjects

MeSH terms (MEDLINE)

XanthomatosisSkin NeoplasmsSkinMohs SurgeryHumansFemaleAged

Author keywords

Mohs micrographic surgeryatypical fibroxanthomaimmunohistochemistrymesenchymal neoplasmskin cancersun-exposed skin

Authors and institutions

  • Rocky Vista University, Ivins, UT, United States.
  • Rocky Vista University, 8401 S Chambers Rd, Englewood, CO, United States, 1 3033732008.
  • Advanced Dermatology and Cosmetic Surgery, Brandon, FL, United States.
  • Advanced Dermatology and Cosmetic Surgery, Delray Beach, FL, United States.

Cite

APA

Tchernogorova, E., Skalka, N., Tidwell, M., Nguyen, B. M., Lanoue, J., Burger, R., & Abercrombie, M. (2026). Atypical Fibroxanthoma Presenting as a Rapidly Enlarging Tender Papule: Case Report. JMIR Dermatology, 9, e84550-e84550. https://doi.org/10.2196/84550

Vancouver

Tchernogorova E, Skalka N, Tidwell M, Nguyen BM, Lanoue J, Burger R, et al. Atypical Fibroxanthoma Presenting as a Rapidly Enlarging Tender Papule: Case Report. JMIR Dermatology. 2026;9:e84550-e84550. doi:10.2196/84550

BibTeX
@article{Tchernogorova2026,
  author = {Tchernogorova, Elizabeth and Skalka, Nicole and Tidwell, Mary and Nguyen, Binh Minh and Lanoue, Julien and Burger, Robin and Abercrombie, McKenna},
  title = {Atypical Fibroxanthoma Presenting as a Rapidly Enlarging Tender Papule: Case Report},
  journal = {JMIR Dermatology},
  year = {2026},
  volume = {9},
  pages = {e84550--e84550},
  doi = {10.2196/84550}
}
Start for free →